Bruce Sizer

2.1k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Bruce Sizer is a scholar working on Oncology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bruce Sizer has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Surgery and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bruce Sizer's work include Colorectal Cancer Surgical Treatments (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Bruce Sizer is often cited by papers focused on Colorectal Cancer Surgical Treatments (8 papers), Radiomics and Machine Learning in Medical Imaging (7 papers) and Colorectal Cancer Treatments and Studies (7 papers). Bruce Sizer collaborates with scholars based in United Kingdom, Germany and Australia. Bruce Sizer's co-authors include Malcolm Crundwell, Carey Hendron, Peter Jenkins, Emma Hall, Nicholas D. James, Jean Tremlett, Robert Huddart, Rachel Waters, Syed A. Hussain and Christine Rawlings and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Bruce Sizer

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

2012 617 citations Nicholas D. James, Syed A. Hussain et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruce Sizer United Kingdom	13	732	469	247	224	131	21	1.1k
Peter Jenkins United Kingdom	17	777 1.1×	386 0.8×	355 1.4×	318 1.4×	200 1.5×	31	1.3k
Reinhard Kühn Germany	16	870 1.2×	198 0.4×	370 1.5×	423 1.9×	103 0.8×	49	1.2k
Тимур Митин United States	15	375 0.5×	358 0.8×	472 1.9×	108 0.5×	137 1.0×	76	885
Nicholas J Sanfilippo United States	18	429 0.6×	405 0.9×	411 1.7×	77 0.3×	103 0.8×	32	995
Kathryn Winter United States	14	905 1.2×	424 0.9×	704 2.9×	237 1.1×	106 0.8×	21	1.4k
Jeff M. Michalski United States	8	805 1.1×	238 0.5×	217 0.9×	287 1.3×	38 0.3×	20	937
Cheryl A. Sadow United States	18	331 0.5×	196 0.4×	291 1.2×	74 0.3×	314 2.4×	34	892
Stefan Tritschler Germany	24	1.0k 1.4×	212 0.5×	601 2.4×	473 2.1×	322 2.5×	88	1.6k
Takafumi Yanagisawa Japan	16	448 0.6×	247 0.5×	557 2.3×	122 0.5×	127 1.0×	152	951
P. Bontemps France	10	415 0.6×	297 0.6×	400 1.6×	42 0.2×	152 1.2×	34	1.1k

Countries citing papers authored by Bruce Sizer

Since Specialization

Citations

This map shows the geographic impact of Bruce Sizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Sizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Sizer more than expected).

Fields of papers citing papers by Bruce Sizer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Sizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Sizer. The network helps show where Bruce Sizer may publish in the future.

Co-authorship network of co-authors of Bruce Sizer

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Sizer. A scholar is included among the top collaborators of Bruce Sizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Sizer. Bruce Sizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boone, Darren, et al.. (2018). Diagnostic accuracy of MRI in assessing tumor regression and identifying complete response in patients with locally advanced rectal cancer after neoadjuvant treatment. Abdominal Radiology. 43(12). 3213–3219. 32 indexed citations

Gollins, Simon, Nicholas P. West, David Sebag‐Montefiore, et al.. (2017). Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations. British Journal of Cancer. 117(9). 1286–1294. 18 indexed citations

Braithwaite, M., et al.. (2017). Nurse-Led Phone Call Follow-Up Clinics Are Effective for Patients With Prostate Cancer. Journal of Patient Experience. 4(3). 114–120. 22 indexed citations

Afaq, Asim, Balaji Ganeshan, Uday Patel, et al.. (2016). Magnetic resonance based texture parameters as potential imaging biomarkers for predicting long‐term survival in locally advanced rectal cancer treated by chemoradiotherapy. Colorectal Disease. 19(4). 349–362. 58 indexed citations

Bhoday, Jemma, Bruce Sizer, Paris Tekkis, et al.. (2016). Results of a prospective randomised control 6 vs 12 trial: Is greater tumour downstaging observed on post treatment MRI if surgery is delayed to 12-weeks versus 6-weeks after completion of neoadjuvant chemoradiotherapy?. Annals of Oncology. 27. vi149–vi149. 28 indexed citations

Hoskin, Peter, Santhanam Sundar, Krystyna Reczko, et al.. (2015). A Multicenter Randomized Trial of Ibandronate Compared With Single-Dose Radiotherapy for Localized Metastatic Bone Pain in Prostate Cancer. JNCI Journal of the National Cancer Institute. 107(10). djv197–djv197. 26 indexed citations

Wasan, Harpreet, Angela Meade, Richard Adams, et al.. (2014). Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial. The Lancet Oncology. 15(6). 631–639. 83 indexed citations

Gollins, Simon, Philip Quirke, Sun Myint, et al.. (2014). Pretreatment and postresection epidermal growth factor receptor (EGFR) pathway mutations in a prospective phase II trial (EXCITE) of preoperative cetuximab-containing chemoradiation (CRT) in locally advanced rectal cancer (LARC).. Journal of Clinical Oncology. 32(3_suppl). 458–458. 1 indexed citations

Araujo, John C., Géralyn C. Trudel, Fred Saad, et al.. (2013). Overall survival (OS) and safety of dasatinib/docetaxel versus docetaxel in patients with metastatic castration-resistant prostate cancer (mCRPC): Results from the randomized phase III READY trial.. Journal of Clinical Oncology. 31(6_suppl). LBA8–LBA8. 36 indexed citations

10.

Sizer, Bruce, et al.. (2013). Malignant melanoma metastasis to the urinary bladder: a rare cystoscopic finding. Journal of Clinical Urology. 8(2). 143–146. 2 indexed citations

11.

James, Nicholas D., Syed A. Hussain, Emma Hall, et al.. (2012). Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer. New England Journal of Medicine. 366(16). 1477–1488. 617 indexed citations breakdown →

12.

Wasan, Harpreet, Richard Adams, Richard H. Wilson, et al.. (2012). Intermittent chemotherapy (CT) plus continuous or intermittent cetuximab (C) in the first-line treatment of advanced colorectal cancer (aCRC): Results of the two-arm phase II randomized MRC COIN-B trial.. Journal of Clinical Oncology. 30(4_suppl). 536–536. 10 indexed citations

13.

Motson, R W, et al.. (2011). Laparoscopic total mesorectal excision following long course chemoradiotherapy for locally advanced rectal cancer. Surgical Endoscopy. 25(6). 1753–1760. 12 indexed citations

14.

Hoskin, Peter, Santhanam Sundar, Krystyna Reczko, et al.. (2011). A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB). European Journal of Cancer. 47. 6–6. 4 indexed citations

15.

Wasan, Harpreet, Richard Adams, Richard H. Wilson, et al.. (2011). 6006 ORAL Intermittent Chemotherapy (CT) Plus Continuous or Intermittent Cetuximab (C) in the First-line Treatment of Advanced Colorectal Cancer (aCRC): Results of the Two-arm Phase II Randomised MRC COIN-B Trial. European Journal of Cancer. 47. S393–S393. 3 indexed citations

16.

Lawrence, Kendall M., et al.. (2009). Locally advanced rectal cancer: histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy. British Journal of Radiology. 82(976). 332–336. 16 indexed citations

17.

Sizer, Bruce, et al.. (2006). QoL and resource use analysis of tegafur-uracil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. Journal of Clinical Oncology. 24(18_suppl). 3631–3631. 5 indexed citations

18.

Oliver, R.T.D., J. Ong, Jonathan Shamash, et al.. (2004). long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy. Urology. 63(3). 556–561. 67 indexed citations

19.

Charman, Susan C., et al.. (2004). Information given to patients about adverse effects of radiotherapy: a survey of patients' views. Clinical Oncology. 16(7). 479–484. 20 indexed citations

20.

Sizer, Bruce. (1991). Bilateral pneumothorax as a presenting feature of metastatic angiosarcoma of the scalp. British Journal of Radiology. 64(757). 72–72. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact